Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shasun Pharma in licensing pact with Debiopharm Group
MoneyControl, India
Sunday, April 14, 2013 - 12:23pm
tags:
Shasun Pharma, Debiopharm
China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare
Seeking Alpha
Sunday, April 14, 2013 - 12:21pm
tags:
OriGene Technologies, Eli Lilly, Tong Ren Tang Technologies, Eddingpharm
Hard Times at Eli Lilly
Motley Fool
Sunday, April 14, 2013 - 12:20pm
tags:
Eli Lilly
Pfizer’s Big Breakthrough for Breast Cancer
Wall Street Cheat Street
Sunday, April 14, 2013 - 12:19pm
tags:
Pfizer, palbociclib, breast cancer
This Week in Biotech
Motley Fool
Sunday, April 14, 2013 - 12:18pm
tags:
Pfizer, Novartis, Acadia, Astex, AcelRx, Synergy Pharmaceuticals
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sunday, April 14, 2013 - 12:16pm
tags:
non-small cell lung cancer, Immunogen, IMGN289, head and neck cancer
An Obesity Drugmaker's Critical Coming Weeks
Motley Fool
Sunday, April 14, 2013 - 12:14pm
tags:
Arena, Qsymia, obesity, weight loss
2 Hot Biotech Stocks to Buy Now
Motley Fool
Sunday, April 14, 2013 - 12:13pm
tags:
Biogen Idec, Celgene
Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara
Pharmabiz
Saturday, April 13, 2013 - 12:27pm
tags:
Valeant Pharmaceuticals, generics, Ziana, Zyclara, Medicis
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, April 13, 2013 - 12:24pm
tags:
Vivus, Cempra, Corcept Therapeutics
Isis Pharmaceuticals - Antisense Making Sense
Seeking Alpha
Saturday, April 13, 2013 - 12:22pm
tags:
Isis Pharmaceuticals, RNA
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, April 13, 2013 - 12:20pm
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
Obama budget is a disaster for drugmakers
Washington Post
Saturday, April 13, 2013 - 12:19pm
tags:
Lupin Launches its Oral Contraceptive Daysee Tablets in the US Market; Generic of Seasonique Tablets
Sacramento Bee, CA
Saturday, April 13, 2013 - 12:16pm
tags:
Daysee, Seasonique, generics, Lupin
FDA Agrees to Priority Review for First ADPKD Therapy
Monthly Prescribing Reference
Saturday, April 13, 2013 - 12:15pm
tags:
Tolvaptan, autosomal dominant polycystic kidney disease
Johnson & Johnson Hopes Its Bet on Biotech Start-Ups Pays Off
CNBC
Saturday, April 13, 2013 - 12:12pm
tags:
JNJ
FDA reviewing heart risks of Glaxo diabetes pill
Yahoo/AP
Saturday, April 13, 2013 - 12:11pm
tags:
GSK, Avandia, diabetes, type 2 diabetes
3 Undeniably Awesome Health Care Dividend Stocks
Motley Fool
Saturday, April 13, 2013 - 12:10pm
tags:
GSK, Merck, Medical Properties Trust
Earnings Preview: J&J 1Q to focus on newest drugs
Yahoo/AP
Saturday, April 13, 2013 - 12:09pm
tags:
earnings, JNJ
Why GlaxoSmithKline Beats AstraZeneca and Shire
Motley Fool
Saturday, April 13, 2013 - 12:08pm
tags:
GSK, AstraZeneca, Shire

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.